Literature DB >> 2478621

Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response.

W Timens1, A Boes, T Rozeboom-Uiterwijk, S Poppema.   

Abstract

The immune response to polysaccharide Ag as present in the capsule of certain virulent bacteria has been demonstrated to be related to a functionally intact spleen. This immune response is almost completely defective in infancy. Because of this the development of cellular compartments in the human spleen was studied immunohistologically in frozen and paraffin tissue sections of 32 infant spleens (less than 2 y of age) and 6 spleens from children. Six cases of sudden infant death syndrome and 7 cases of infection or sepsis which were included showed no significant differences compared to the other cases. Whereas all other cellular compartments have completed their maturation to an adult-type immunophenotype and morphology within the first 5 mo, the infant marginal zone B cells show essentially different features compared to the adult situation. The main characteristics of the infant marginal zone B cells are the absence of CD21-(C3d/EBV-R) expression and the high percentage of cells strongly coexpressing IgM and IgD. As the marginal zone is supposed to be the site of the initiation of the immune response to polysaccharide Ag, there is a remarkable coincidence between the first appearance of MZ B cells with adult features, and the time of acquisition of the ability to mount an immune response to polysaccharides, including encapsulated bacteria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478621

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

Review 1.  Regeneration of autotransplanted splenic fragments: basic immunological and clinical relevance.

Authors:  R Pabst
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

Review 2.  Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens.

Authors:  C G Vinuesa; C de Lucas; M C Cook
Journal:  Postgrad Med J       Date:  2001-09       Impact factor: 2.401

3.  Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection.

Authors:  Natalie J Thornburg; Bryan Shepherd; James E Crowe
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

4.  Induction of a protective capsular polysaccharide antibody response to a multiepitope DNA vaccine encoding a peptide mimic of meningococcal serogroup C capsular polysaccharide.

Authors:  Deborah M Prinz; S Louise Smithson; Thomas Kieber-Emmons; M A Julie Westerink
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

Review 5.  T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens.

Authors:  A Jeurissen; J L Ceuppens; X Bossuyt
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

6.  The spleen? Who needs it anyway?

Authors:  M Hazlewood; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

7.  Phenotypic analysis of pneumococcal polysaccharide-specific B cells.

Authors:  Noor Khaskhely; Jason Mosakowski; Rebecca S Thompson; Sadik Khuder; S Louise Smithson; M A Julie Westerink
Journal:  J Immunol       Date:  2012-01-23       Impact factor: 5.422

Review 8.  The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens.

Authors:  A Zandvoort; W Timens
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

9.  Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors.

Authors:  B L Ferry; S A Misbah; P Stephens; Z Sherrell; H Lythgoe; E Bateman; C Banner; J Jones; N Groome; H M Chapel
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

10.  An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular polysaccharide antibodies.

Authors:  M A Hazlewood; D S Kumararatne; A D Webster; M Goodall; P Bird; M Daha
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.